Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study-Reference-Cited by-同舟云学术

Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study

Published:2016-12-01 Issue:12 Volume:46 Page:1088-1094
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Masuda Norikazu,Iwata Hiroji,Aogi Kenjiro,Xu Yihuan,Ibrahim Ayman,Gao Ling,Dalal Rita,Yoshikawa Reigetsu,Sasaki Yasutsuna

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/46/12/1088/26367957/hyw127.pdf

Reference19 articles.

1. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project;Matsuda;Jpn J Clin Oncol,2014

2. An overview of the Japan Breast Cancer Research Group (JBCRG) activities;Ohno;Breast Cancer,2013

3. An updated report of the trends in cancer incidence and mortality in Japan;Katanoda;Jpn J Clin Oncol,2013

4. Vascular endothelial growth factor receptor-1 expression in breast cancer and its correlation to vascular endothelial growth factor A;Srabovic;Int J Breast Cancer,2013

5. Angiogenesis in cancer: anti-VEGF escape mechanisms;Prager;Transl Lung Cancer Res,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression;Cancers;2023-05-08

2. Anti-vascular endothelial growth factor therapy in breast cancer: Molecular pathway, potential targets, and current treatment strategies;Cancer Letters;2021-11

3. Efficacies of programmed cell death 1 ligand 1 blockade in non-small cell lung cancer patients with acquired resistance to prior programmed cell death 1 inhibitor and development of diabetic ketoacidosis caused by two different etiologies: a retrospective case series;Endocrine Journal;2021

4. Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study;Gastric Cancer;2018-03-05

5. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial;The Lancet;2017-11